期刊文献+

急性冠脉综合征生化诊断标志物临床研究进展 被引量:3

下载PDF
导出
摘要 急性冠脉综合征(acute coronary syndrome.ACS)是包括不稳定型心绞痛(unstable angina,UA)、非ST段抬高型心肌梗死和ST段抬高型心肌梗死等的一组临床综合征,
出处 《实用检验医师杂志》 2013年第2期120-123,共4页 Chinese Journal of Clinical Pathologist
  • 相关文献

参考文献8

二级参考文献80

  • 1范长青,王斌,王冬元,刘丕栋,田野,杨巍,傅世英.C反应蛋白质量浓度与不稳定型心绞痛病人冠状动脉影像学特点的关系[J].中国实用内科杂志,2004,24(10):622-623. 被引量:24
  • 2王玉凤,柳茵,严鹏仲,李琳.术前口服β-受体阻滞剂对冠心病患者介入治疗后血清CK-MB水平影响的研究[J].中国实用内科杂志,2004,24(9):552-553. 被引量:1
  • 3张鹏,王前,郑磊,曾方银,裘宇容.心肌型脂肪酸结合蛋白早期诊断急性冠脉综合征[J].南方医科大学学报,2006,26(3):358-360. 被引量:11
  • 4Glatz JF, Storch J. Unravelling the significance of cellular fatty acid- binding proteins. Curr Opin Lipidol, 2001, 12(3) :267
  • 5Ishii J, Wang JH, Naruse H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem, 1997, 43 (8):1372
  • 6Okamoto F, Sohmiya K, Ohkaru Y, et al. Human heart-type cytoplasmic fatty add-binding protein(H-FABP) for the diagnosis of acute myocardial infarction. Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB. Clin Chem Lab Med, 2000, 38(3) :231
  • 7Chan CPY, Sanderson JE, Glanz JFC, et al. A super early myoear dial infarction marker - Human heart type fatty add binding protein. Z Kardiol, 2004, 93:388
  • 8Vittorini S, Clerico A. Cardiovascular biomarkers: increasing impact of laboratory medicine in cardiology practice [J]. Clin Chem Lab Med, 2008:748-763.
  • 9Ladue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction[J]. Science 1954, 120:497-499.
  • 10Wu AH, Apple FS, Gibler WB. et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice. Recommendation for the use of cardiac markers in coronary artery diseases[J]. Clin Chem, 1999,45:1104-1121.

共引文献77

同被引文献40

  • 1张伟丽,宋雷,陈宇,刘继斌,吴永健,惠汝太.急性冠脉综合征的药物基因组学研究进展[J].中国分子心脏病学杂志,2011,11(4):251-256. 被引量:2
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 3White HD,Thygesen K,Alpert JS,et al.Clinical implications of the Third Universal Definition of Myocardial Infarction[J].Heart,2014(100):424-432.
  • 4Pawlus J,Rusak M,Choeiej-Stypulkowska J,et al.Parameters of platelets activation and myeloperoxidase concentration as mal'kers of coronary disease[J].Pol Merkur Lekarski,2010(29):259-262.
  • 5Rudolph V,Goldmann BU,Bos C,et al.Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction[J].Cardiol,2011(153):267-271.
  • 6Maguire OC,Cunninngham SK.Ischaemia-modified albumin:factor Fiction[J].Ann Clin Biochem,2010(47):182-183.
  • 7Shen XL,Lin CJ,Han LL,et al.Assessment of ischemia-modified albumin levels for emergency room diagnosis of acute coronary syndmme[J].Int J Cardiol,2011(149):296-298.
  • 8Sbarouni E,Georgiadou P,Voudris V.Ischemia modified albumin changes-review and clinical implications[J].Clin Chem Lab Med,2011(49):177-184.
  • 9Sinha MK,Roy D,Gaze DC,et al.Role of"ischemia modifled albumin".a new biochemical marker of myocardial i Schaemia in the early diagnosis of acute coronary syndromes[J].Emerg Med J,2004,21(1):29-34.
  • 10Mc Mahon CG,Lamont JV,Cartin E,et al.Diagnostic accuracy 0f hean-type fatty acid-binding protein for the eady diagnosis of acute myocardial infarction[J].The America Il Joumal of Emergency Medicine,2012,30(2):267-274.

引证文献3

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部